Q2 2013

Filed Sep 6, 2013 · 10-Q · 68 days after period end · 0001193125-13-359997

Q2 2013 · 10-Q

Revenue

$0.00

no prior Q2 2012 on file

Net Income

-$266.90K

no prior Q2 2012 on file

EPS Diluted

-$0.01

no prior Q2 2012 on file

Operating Income-$403,580—

Operating Cash Flow

Same quarter

no prior Q2 2012 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2013 · filed Sep 6, 2013 · 68 d after period end

Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR